Sponsor pipeline

International Extranodal Lymphoma Study Group (IELSG) clinical trial pipeline

Get alerts when International Extranodal Lymphoma Study Group (IELSG)'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 2
4
Phase 3
1
Not charted: 6 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT05735834 Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated… Splenic Marginal Zone Lymphoma Active, Not Recruiting 2026-07-22
Phase 2
NCT03697512 MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas Marginal Zone Lymphoma Active, Not Recruiting 2026-04-08
NCT04417166 Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma Lymphoma, Extranodal NK-T-Cell Active, Not Recruiting 2026-04-07
NCT04646395 Study of Acalabrutinib and Tafasitamab in MZL Patients Marginal Zone Lymphoma Active, Not Recruiting 2026-04-06
NCT01808599 Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal… MALT Lymphoma Active, Not Recruiting 2026-01-15
Not applicable
NCT01599559 Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of… Primary Mediastinal B-cell Lymphoma Active, Not Recruiting 2026-01-15
Not specified
NCT05700149 Integrated Molecular and Clinical Profiling to Improve Disease Characterization and… Nodal Marginal Zone Lymphoma Recruiting 2026-06-22
NCT06712459 Integrated Molecular and Clinical Profiling of Transformed Splenic Marginal Zone Lymphoma Transformed Splenic Marginal Zone Lymphoma Recruiting 2026-01-16
NCT04333524 FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role Marginal Zone Lymphoma Active, Not Recruiting 2026-07-24
NCT07147751 Characterization of Primary Central Nervous System Diffuse Large B Cell Lymphoma… Primary Central Nervous System Diffuse Large B Cell Lymphoma (PCNS-DLBCL) Not Yet Recruiting 2026-06-22
NCT07376330 Molecular and Cellular Characterization of MALT Lymphoma MALT Lymphoma Not Yet Recruiting 2026-06-22

Disease areas by active trials

Non-Hodgkin Lymphoma (11) · DLBCL (1)

Get alerts when International Extranodal Lymphoma Study Group (IELSG)'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free